FOLFIRI+BEVA; FOLFIRI
Bevacizumab, fluorouracil and irinotecan drug monographs, Cancer Care Ontario.
André T, Louvet C, Maindrault-Goebel F, et al: CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR. Eur J Cancer 35:1343-1347, 1999.
Clinical Practice Guidelines in Oncology (NCCN Guidelines). Colon Cancer. Version 3.2015. NCCN.org
Douillard JY, Cunningham D, Roth AD et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial. The Lancet, March 2000; 355: 1041-47.
Hurwitz H, Fehrenbacher L, Novotny W et al. Bevacizumab plus irinotecan, fluorouracil and leucovorin in metastatic colorectal cancer. N Engl J Med. 2004; 350: 2335-42.
Mahfoud T, Tanz R, Mesmoudi M, et al. Bevacizumab 5 or 7.5 mg/kg in Metastatic Colorectal Cancer Can Be Infused Safely Over 10 Minutes. J Gastrointest Cancer. 2011 Jan 4. [Epub ahead of print] Reidy DL, Chung KY, Timoney JP, et al. Bevacizumab 5 mg/kg can be infused safely over 10 minutes. J Clin Oncol. 2007;25(19):2691-5.
National Comprehensive Cancer Network. Colon Cancer (Version 2.2017). https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Accesse....
Reidy DL, Chung KY, Timoney JP, et al. Bevacizumab 5 mg/kg can be infused safely over 10 minutes. Journal of Clinical Oncology 2007; 25: 2691-5.
Sobrero A, Ackland S, Clarke S, et al. Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer. Oncology 2009; 77: 113-9.
Tournigand C, André T, Achile E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004; 22(2): 229-37.
Van Cutsem E, Rivera F, Berry S, et al. Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol 2009; 20: 1842-7.
Zaanan A, Costes L, Gaauthier M et al. Chemotherapy of advanced small-bowel adenocarcinoma: a multicentre AGEO study. Ann Oncol 2010; 21: 1786-93.
Cancer Type: Gastrointestinal Colorectal Small bowel and appendix Type of Content: Regimen Regimen Code:FOLFIRI
FOLFIRI+BEVA
Intent: Palliative Regimen Category:Evidence-Informed
Funding Program:New Drug Funding Program
Funding Instance:- Bevacizumab (Biosimilar) - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer
FOLFIRI ± BEVA_GI_COL_P
Regimen Monograph Body:
Small bowel and appendix
Regimen is considered appropriate as part of the standard care of patients; meaningfully improves outcomes (survival, quality of life), tolerability or costs compared to alternatives (recommended by the Disease Site Team and national consensus body e.g. pan-Canadian Oncology Drug Review, pCODR). Recommendation is based on an appropriately conducted phase III clinical trial relevant to the Canadian context OR (where phase III trials are not feasible) an appropriately sized phase II trial. Regimens where one or more drugs are not approved by Health Canada for any indication will be identified under Rationale and Use.
Treatment of metastatic colorectal, small bowel or appendiceal cancer
bevacizumab
New Drug Funding Program
(Bevacizumab (Biosimilar) - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer)
(NDFP Website
)
Different bevacizumab products are not interchangeable.
irinotecan | 180 mg /m² | IV over 90 minutes | Day 1 |
leucovorin 1
| 400 mg /m² | IV over 120 minutes concurrently with irinotecan | Day 1 |
fluorouracil | 400 mg /m² | IV bolus, after leucovorin | Day 1 |
THEN
|
|||
fluorouracil 2
| 2400 mg /m² | IV continuous infusion over 46 hours only | Start on Day 1 |
with or without:
|
|||
bevacizumab 3, 4 | 5 mg /kg | IV over 90 minutes for initial dose | Day 1 |
Irinotecan and leucovorin may be infused at the same time by using a y-connector, but not in the same bag, then fluorouracil.
1Commercially available form is d,l-racemic. Some studies specified the dose of leucovorin as 200mg/m² in the l-isomer form. Since only the l-isomer is active in the racemic form, thus the dose is doubled.
2 Dose may be escalated to 3000 mg/m² if toxicity ≤ grade 1 during the first two cycles.
3 If tolerated, next infusion can be given over 60 minutes; can thereafter be given over 30 minutes as maintenance dose. Alternative administration rates have been described by Mahfoud et al and Reidy et al, but these have not been approved by Health Canada.
4 Sequence of administration: Bevacizumab has been given prior to chemotherapy in several phase III clinical trials.
REPEAT EVERY 14 DAYS
Until evidence of disease progression or unacceptable toxicity
Moderate
Other Supportive Care:
- Irinotecan:
- Unless contraindicated, atropine 0.25-1mg IV/SC may be used for cholinergic adverse effects (early diarrhea)
- Diarrhea (abdominal cramp = diarrhea) may be severe and delayed with irinotecan; use loperamide 4mg at the onset of diarrhea, then 2mg q2h until patient is diarrhea-free for 12 hours
- Patients with ileus, fever or febrile neutropenia should receive antibiotics
- 5FU:
- May advise patients to suck on ice chips during bolus injection of 5FU, to reduce stomatitis
Also refer to CCO Antiemetic Summary
Doses should be modified according to the protocol by which the patient is being treated.
Patients should be tested for DPD deficiency before starting treatment with fluorouracil. Refer to the DPD Deficiency Guidance for Clinicians for more information.
In patients with unrecognized DPD deficiency, acute, life-threatening toxicity may occur; if grade 2-4 acute toxicity develops, treatment should be stopped immediately and permanent discontinuation considered based on clinical assessment of the toxicities.
Refer to bevacizumab drug monograph for additional details on bevacizumab.
Dosage with toxicity
See general recommendations for hematologic toxicity.
FOLFIRI
Patients should not be re-treated with irinotecan until recovery (to baseline) from GI toxicity (without loperamide for at least 24 hours) has occurred, platelets ≥ 100 x 109/L, and ANC ≥ 1.5 x 109/L. All dose adjustments should be based on the worst preceding toxicity.
Patients with ileus, fever or febrile neutropenia should receive antibiotics.
Do not use in patients with ECOG PS of 3 or 4, nor in patients with moderate or severe increases in bilirubin.
Consider a reduction in the starting dose described below for elderly patients (≥ 70 years), patients with prior abdominal or pelvic irradiation, patients with a poor performance status (ECOG of 2), patients with mild increases in bilirubin (including Gilbert’s syndrome), patients homozygous for UGT1A1*28 allele or patients with a history of myelosuppression with previous treatment.
Suggested Dose Levels:
Regimen
|
Drug
|
Starting dose (mg/m2)
|
Dose level -1 (mg/m2)
|
Dose Level -2 (mg/m2)
|
FOLFIRI
|
Irinotecan
|
180
|
150
|
120
|
Leucovorin infusion
|
400
|
No change
|
No change
|
|
5-FU bolus
|
400
|
320
|
240
|
|
5-FU infusion
(start day 1 over 46h*)
|
2400
|
2000
|
1600
|
* This 5-FU dosing is not approved by Health Canada, but has been used in some phase III trials.
Dosage with Toxicity:
Dose Adjustments for Irinotecan in Combination with Fluorouracil:
Worst Toxicity Grade from Previous Cycle |
At the start of subsequent cycles1, 2 (FOLFIRI) |
|
Hematologic |
||
Grade 1 |
No change |
|
Grade 2 |
No change |
|
Grade 3 |
reduce by 1 dose level |
|
Grade 4 or febrile neutropenia |
reduce by 2 dose levels |
|
Diarrhea |
||
Grade 1: 2-3/day > pre-treatment |
No change |
|
Grade 2: 4-6/day > pre-treatment |
No change |
|
Grade 3: 7-9/day > pre-treatment |
reduce by 1 dose level |
|
Grade 4: ≥10/day > pre-treatment |
reduce by 2 dose levels |
|
Other Non-hematologic toxicities (excludes alopecia, anorexia and fatigue). For mucositis/stomatitis, decrease 5FU only. |
||
Grade 1 |
No change |
|
Grade 2 |
Hold until ≤ grade 1, no change in dose |
|
Grade 3 |
Hold until ≤ grade 2, reduce by 1 dose level |
|
Grade 4 |
Hold until ≤ grade 2, reduce by 2 dose levels |
|
1 Relative to the starting dose used in the previous cycle. 2 Patients should not be retreated until GI toxicity resolved to baseline (without loperamide for at least 24 h), platelets ≥ 100 x 109/L, and ANC ≥ 1.5 x 109/L. If no recovery after a 2-week delay, consider discontinuing treatment. |
Hepatic Impairment
No dose adjustment required for leucovorin. OMIT leucovorin if 5FU is omitted.
Transaminases |
Bilirubin
|
Irinotecan
|
5FU
|
|
1-1.5 X ULN or Gilbert's
|
Consider ↓
|
No change
|
> 3 X ULN*
|
2-4 X ULN
|
Omit
|
No change
|
|
> 4 XULN
|
Omit
|
Omit
|
* or 5 X ULN with liver metastases; consider investigating for reversible causes such as biliary obstruction and reevaluate after stent
|
Renal Impairment
No dose adjustment required for leucovorin.
Creatinine Clearance (mL/min) |
Fluorouracil (% previous dose) |
Irinotecan (% previous dose) |
>60 |
No change | No change |
30-60 |
No change |
Caution; no data available |
<30 |
Caution; consider dose ↓ |
Caution; no data available |
Dosage in the elderly
Consider reducing starting dose for patients ≥ 70 years. Monitor patients ≥ 65 years closely.
Refer to irinotecan, leucovorin, fluorouracil (± bevacizumab) drug monograph(s) for additional details of adverse effects
The following adverse effects table is related to FOLFIRI+BEVA:
Very common (≥ 50%) |
Common (25-49%) |
Less common (10-24%) |
Uncommon (< 10%), but may be severe or life-threatening |
|
|
|
|
Refer to irinotecan, leucovorin, fluorouracil drug monograph(s) for additional details
Refer to bevacizumab drug monograph for additional details on bevacizumab.
Refer to irinotecan, leucovorin, fluorouracil drug monograph(s) for additional details
Different bevacizumab products are not interchangeable.
Refer to bevacizumab drug monograph for additional details on bevacizumab.
Refer to bevacizumab drug monograph for additional details on bevacizumab
Treating physicians may decide to monitor more or less frequently for individual patients but should always consider recommendations from the product monograph.
Recommended Clinical Monitoring
- CBC, electrolytes, liver & renal function tests; baseline and before each cycle
- Clinical toxicity assessment (including diarrhea, infection, dehydration, stomatitis, nausea and vomiting, fatigue and cardiac effects); at each visit
- Close monitoring of above parameters in elderly patients and patients who are receiving pelvic radiotherapy.
-
Grade toxicity using the current NCI-CTCAE (Common Terminology Criteria for Adverse Events) version
Suggested Clinical Monitoring
Blood glucose, especially in patients with diabetes; baseline and regular
back to top
Bevacizumab, fluorouracil and irinotecan drug monographs, Cancer Care Ontario.
André T, Louvet C, Maindrault-Goebel F, et al: CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR. Eur J Cancer 35:1343-1347, 1999.
Clinical Practice Guidelines in Oncology (NCCN Guidelines). Colon Cancer. Version 3.2015. NCCN.org
Douillard JY, Cunningham D, Roth AD et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial. The Lancet, March 2000; 355: 1041-47.
Hurwitz H, Fehrenbacher L, Novotny W et al. Bevacizumab plus irinotecan, fluorouracil and leucovorin in metastatic colorectal cancer. N Engl J Med. 2004; 350: 2335-42.
Mahfoud T, Tanz R, Mesmoudi M, et al. Bevacizumab 5 or 7.5 mg/kg in Metastatic Colorectal Cancer Can Be Infused Safely Over 10 Minutes. J Gastrointest Cancer. 2011 Jan 4. [Epub ahead of print] Reidy DL, Chung KY, Timoney JP, et al. Bevacizumab 5 mg/kg can be infused safely over 10 minutes. J Clin Oncol. 2007;25(19):2691-5.
National Comprehensive Cancer Network. Colon Cancer (Version 2.2017). https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Accessed June 30, 2017.
Reidy DL, Chung KY, Timoney JP, et al. Bevacizumab 5 mg/kg can be infused safely over 10 minutes. Journal of Clinical Oncology 2007; 25: 2691-5.
Sobrero A, Ackland S, Clarke S, et al. Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer. Oncology 2009; 77: 113-9.
Tournigand C, André T, Achile E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004; 22(2): 229-37.
Van Cutsem E, Rivera F, Berry S, et al. Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol 2009; 20: 1842-7.
Zaanan A, Costes L, Gaauthier M et al. Chemotherapy of advanced small-bowel adenocarcinoma: a multicentre AGEO study. Ann Oncol 2010; 21: 1786-93.
- Continuous versus Intermittent Chemotherapy Strategies in Inoperable, Advanced Colorectal Cancer
- Strategies of Sequential Therapies in Unresectable, Metastatic Colorectal Cancer Treated with Palliative Intent
- The Role of Primary Tumour Location in the Selection of Biologics for the Treatment of Unresectable Metastatic Colorectal Cancer
April 2023 Updated DPD deficiency information in the Dose Modifications section and fluorouracil antidote information in the Other Notes section.
Diarrhea can be severe, with either immediate or delayed onset. Patients must be instructed in the use of Loperamide as treatment for diarrhea, and must have a supply of this drug upon starting Irinotecan treatments.
Antidote for Fluorouracil Overdose:
Uridine triacetate is a prodrug of uridine and is a specific antidote for treating fluorouracil overdose or severe early onset toxicities. If available, consider administering as soon as possible (i.e. within 96 hours) for suspected overdose. If not available, treatment is symptomatic and supportive.
For usage approval and supply, contact Health Canada’s Special Access Program (SAP) (Phone: 613-941-2108. On-call service is available for emergencies). Uridine triacetate (Vistogard®) is supplied by its manufacturer in the United States (Wellstat Therapeutics).
The recommended dosing and administration for uridine triacetate in patients ≥18 years is:
- 10 grams (1 packet of coated granules) orally every 6 hours for 20 doses in total, without regards to meals.
- Granules should not be chewed. They should be mixed with 3 to 4 ounces of soft foods such as applesauce, pudding or yogurt.
- The dose should be ingested within 30 minutes of preparation, followed by at least 4 ounces of water.
- Refer to the prescribing information on dose preparation for NG-tube or G-tube use.
Additional resources on the management of fluorouracil infusion overdose:
- Management of Fluorouracil Infusion Overdose Guideline (Alberta Health Services)
- Management of Fluorouracil Infusion Overdose at the BCCA - Interim Guidance (BC Cancer Agency)
Regimen Abstracts
A Regimen Abstract is an abbreviated version of a Regimen Monograph and contains only top level information on usage, dosing, schedule, cycle length and special notes (if available). It is intended for healthcare providers and is to be used for informational purposes only. It is not intended to constitute or be a substitute for medical advice, and all uses of the Regimen Abstract are subject to clinical judgment. Such information is provided on an “as-is” basis, without any representation, warranty, or condition, whether express, or implied, statutory or otherwise, as to the information’s quality, accuracy, currency, completeness, or reliability, and Cancer Care Ontario disclaims all liability for the use of this information, and for any claims, actions, demands or suits that arise from such use.
Information in regimen abstracts is accurate to the extent of the ST-QBP regimen master listings, and has not undergone the full review process of a regimen monograph. Full regimen monographs will be published for each ST-QBP regimen as they are developed.
Regimen Monographs
Refer to the New Drug Funding Program or Ontario Public Drug Programs websites for the most up-to-date public funding information.
The information set out in the drug monographs, regimen monographs, appendices and symptom management information (for health professionals) contained in the Drug Formulary (the "Formulary") is intended for healthcare providers and is to be used for informational purposes only. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects of a particular drug, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for a given condition. The information in the Formulary is not intended to constitute or be a substitute for medical advice and should not be relied upon in any such regard. All uses of the Formulary are subject to clinical judgment and actual prescribing patterns may not follow the information provided in the Formulary.
The format and content of the drug monographs, regimen monographs, appendices and symptom management information contained in the Formulary will change as they are reviewed and revised on a periodic basis. The date of last revision will be visible on each page of the monograph and regimen. Since standards of usage are constantly evolving, it is advised that the Formulary not be used as the sole source of information. It is strongly recommended that original references or product monograph be consulted prior to using a chemotherapy regimen for the first time.
Some Formulary documents, such as the medication information sheets, regimen information sheets and symptom management information (for patients), are intended for patients. Patients should always consult with their healthcare provider if they have questions regarding any information set out in the Formulary documents.
While care has been taken in the preparation of the information contained in the Formulary, such information is provided on an “as-is” basis, without any representation, warranty, or condition, whether express, or implied, statutory or otherwise, as to the information’s quality, accuracy, currency, completeness, or reliability.
CCO and the Formulary’s content providers shall have no liability, whether direct, indirect, consequential, contingent, special, or incidental, related to or arising from the information in the Formulary or its use thereof, whether based on breach of contract or tort (including negligence), and even if advised of the possibility thereof. Anyone using the information in the Formulary does so at his or her own risk, and by using such information, agrees to indemnify CCO and its content providers from any and all liability, loss, damages, costs and expenses (including legal fees and expenses) arising from such person’s use of the information in the Formulary.
FOLFIRI Treatment
This handout gives general information about this cancer treatment.
You will learn:
-
who to contact for help
-
what the treatment is
-
how it is given
-
what to expect while on treatment
This handout was created by Ontario Health (Cancer Care Ontario) together with patients and their caregivers who have also gone through cancer treatment. It is meant to help support you through your cancer treatment and answer some of your questions.
This information does not replace the advice of your health care team. Always talk to your health care team about your treatment.
My cancer health care provider is: _____________________________________________
During the day I should contact: _______________________________________________
Evenings, weekends and holidays: _____________________________________________
This page gives general information about this cancer treatment.
You will learn:
-
who to contact for help
-
what the treatment is
-
how it is given
-
what to expect while on treatment
This information was created by Ontario Health (Cancer Care Ontario) together with patients and their caregivers who have also gone through cancer treatment. It is meant to help support you through your cancer treatment and answer some of your questions.
This information does not replace the advice of your health care team. Always talk to your health care team about your treatment.
FOLFIRI is the code name of your colorectal cancer treatment regimen.
A regimen is a combination of medications to treat cancer.
This regimen name is made up of one or more letters from the names of the 3 medications in your treatment.
Here are the names of the medications in this regimen:
FOL = FOLinic acid (also called leucovorin)
F = Fluorouracil (also called 5-FU)
IRI = IRInotecan
Treatment is divided into cycles. Each cycle is 2 weeks long. Your health care team will tell you how many cycles you need.
Here is a picture of the schedule for FOLFIRI treatment:
Cycle 1 FOLFIRI (2 weeks)
Repeat FOLFIRI (2 weeks)
Your health care team will tell you how many cycles you will have.
During each 2-week cycle, you will have FOLFIRI treatment on day 1 at the hospital. Your nurse will also start an infusion (IV) of fluorouracil that will continue at home for a total of 46 hours. See below for more information.
Each cycle looks like this:
Day 1
Treatment Day:
Go to the hospital for FOLFIRI treatment.
Fluorouracil infusion will
continue for 46 hours.
2
Fluorouracil infusion continues at home.
3
Fluorouracil infusion continues at home. A nurse will disconnect it.
4
No
FOLFIRI
Treatment
5
6
7
8
9
10
11
12
13
14
Remember To:
-
Tell your health care team about all of the other medications you are taking.
-
Keep taking other medications that have been prescribed for you, unless you have been told not to by your health care team.
Your health care team may ask you to have a blood test to check for DPD deficiency before starting treatment.
- DPD deficiency is when you have low or no activity of an enzyme called DPD (dihydropyrimidine dehydrogenase). A deficiency can cause you to have severe side effects from fluorouracil.
- See the Testing for people taking capecitabine or 5-fluorouracil (5-FU) pamphlet for more information.
You will have a blood test to check for hepatitis B before starting treatment. See the Hepatitis B and Cancer Medications pamphlet for more information.
The medications in your treatment are given through an IV (injected into a vein) at the hospital on day 1 of your treatment. You will also be given a device to take home that will continue to give you fluorouracil at home. The device looks like a bottle. It slowly gives you fluorouracil over 46 hours.
Your health care team may suggest that you get a PICC line or a Port-a-Cath.
-
These are special IV’s used to give medicines and fluids into larger veins.
-
A PICC or Port-a-Cath can be safer for some medications that can cause reactions
when given through an IV in your hand. -
If you have a PICC or Port-a-Cath you do not need an IV (needle) put into your arm
every time you come for treatment.
- Talk to your healthcare team about the benefits and risks of a PICC or a Port-a-Cath to see if one of these options is right for you.
You will have a blood test before each treatment cycle to make sure it is safe for you to get treatment.
To Prevent Nausea and Vomiting
You will be given medications to help prevent nausea (feeling like throwing up) and vomiting (throwing up) before they start.
-
These are called anti-nausea medications and include medications such as ondansetron (Zofran®), granisetron (Kytril®), dexamethasone or others.
To Treat Diarrhea
The Irinotecan in your treatment regimen can cause diarrhea. Diarrhea is when you have loose bowel movements (watery poo) or you need to have bowel movements (go poo) more often than usual. Diarrhea may start a few days after your treatment.
You will be given a medication called loperamide (Imodium®) to help treat your diarrhea. Take this medication only if you need it.
Keep your loperamide with you all the time. When diarrhea starts, take the loperamide right away.
If you start to have diarrhea:
- Take 2 tablets (4 mg) of loperamide right away.
- Take 1 tablet (2 mg) every 2 hours after that.
- During the night you may take 2 tablets (4 mg) every 4 hours.
- Keep taking loperamide until you have no diarrhea for 12 hours.
-
DO tell your health care team about any other medical conditions that you have such as heart, liver, lung or kidney problems, diabetes or any allergies.
-
DO check with your health care team before getting any vaccinations, surgery, dental work or other medical procedures.
-
DO protect your skin from the sun. Wear a long sleeved shirt, long pants and a hat. Apply sunscreen with UVA and UVB protection and an SPF of at least 30. Your skin may be more sensitive to the sun and you could develop a bad sunburn or rash more easily.
-
DO talk to your health care team about your risk of getting other cancers and heart problems with this treatment.
-
DO consider asking someone to drive you to and from the hospital on your treatment days. You may feel drowsy or dizzy after your treatment.
- DO NOT take any other medications, such as vitamins, over-the-counter (non-prescription) drugs, or natural health products without checking with your health care team.
- DO NOT start any complementary or alternative therapies, such as acupuncture or homeopathic medications, without checking with your health care team.
- DO NOT eat or drink grapefruit, starfruit, Seville oranges or their juices (or products that contain these) while on this treatment. They may increase side effects.
- DO NOT smoke or drink alcohol while on treatment without talking to your health care team first. Smoking and drinking can make side effects worse and make your treatment not work as well.
-
DO tell your health care team about any other medical conditions that you have such as heart, liver, lung or kidney problems, diabetes or any allergies.
-
DO check with your health care team before getting any vaccinations, surgery, dental work or other medical procedures.
-
DO protect your skin from the sun. Wear a long sleeved shirt, long pants and a hat. Apply sunscreen with UVA and UVB protection and an SPF of at least 30. Your skin may be more sensitive to the sun and you could develop a bad sunburn or rash more easily.
-
DO talk to your health care team about your risk of getting other cancers and heart problems with this treatment.
-
DO consider asking someone to drive you to and from the hospital on your treatment days. You may feel drowsy or dizzy after your treatment.
- DO NOT take any other medications, such as vitamins, over-the-counter (non-prescription) drugs, or natural health products without checking with your health care team.
- DO NOT start any complementary or alternative therapies, such as acupuncture or homeopathic medications, without checking with your health care team.
- DO NOT eat or drink grapefruit, starfruit, Seville oranges or their juices (or products that contain these) while on this treatment. They may increase side effects.
- DO NOT smoke or drink alcohol while on treatment without talking to your health care team first. Smoking and drinking can make side effects worse and make your treatment not work as well.
Yes, the medications in this regimen can interact with other medications, vitamins, foods and natural health products. Interactions can make the treatment not work as well or cause severe side effects.
Tell your health care team about all of your:
- prescription and over-the-counter (non-prescription) medications
- natural health products such as vitamins, herbal teas, homeopathic medicines, and other supplements
Check with your health care team before starting or stopping any of them.
If you are taking seizure medications (such as phenytoin), your health care team will monitor your blood levels closely and may change your dose.
- Anti-inflammatory medications such as ibuprofen (Advil® or Motrin®), naproxen (Aleve®) or Aspirin®.
- Over-the-counter products such as dimenhydrinate (Gravol®)
- Natural health products such as St. John’s Wort
- Supplements such as vitamin C
- Alcoholic drinks
- Tobacco
- All other drugs, such as marijuana or cannabis (medical or recreational)
-
Always check your temperature to see if you have a fever before taking any medications for fever or pain (such as acetaminophen (Tylenol®) or ibuprofen (Advil®)).
-
Fever can be a sign of infection that may need treatment right away.
-
If you take these medications before you check for fever, they may lower your temperature and you may not know you have an infection.
-
How to check for fever:
Keep a digital (electronic) thermometer at home and take your temperature if you feel hot or unwell (for example, chills, headache, mild pain).
-
You have a fever if your temperature taken in your mouth (oral temperature) is:
-
38.3°C (100.9°F) or higher at any time
-
-
OR
-
38.0°C (100.4°F) or higher for at least one hour.
-
If you do have a fever:
-
Try to contact your health care team. If you are not able to talk to them for advice, you MUST get emergency medical help right away.
-
Ask your health care team for the Fever pamphlet for more information.
If you do not have a fever but have mild symptoms such as headache or mild pain:
- Ask your health care team about the right medication for you. Acetaminophen (Tylenol®) is a safe choice for most people.
Talk to your health care team before you start taking ibuprofen (Advil®, Motrin®), naproxen (Aleve®) or ASA (Aspirin®), as they may increase your chance of bleeding or interact with your cancer treatment.
Talk to your health care team if you already take low dose aspirin for a medical condition (such as a heart problem). It may still be safe to take.
Talk to your health care team about:
-
How this treatment may affect your sexual health.
-
How this treatment may affect your ability to have a baby, if this applies to you.
This treatment may harm an unborn baby. Tell your health care team if you or your partner are pregnant, become pregnant during treatment, or are breastfeeding.
- If there is any chance of pregnancy happening, you and your partner together must use 2 effective forms of birth control at the same time while you are on treatment. Talk to your health care team about which birth control options are best for you, and how long you should use them after your last treatment dose.
- Do not breastfeed while on this treatment. Talk to your health care team about how long to wait before you start breastfeeding after your last treatment dose, if this applies to you.
The following table lists side effects that you may have when getting FOLFIRI treatment. The table is set up to list the most common side effects first and the least common last. It is unlikely that you will have all of the side effects listed and you may have some that are not listed.
Read over the side effect table so that you know what to look for and when to get help. Keep this paper during your treatment so that you can refer to it if you need to.
It is common for people who are treated with FOLFIRI to have mild side effects only.
Very Common Side Effects (50 or more out of 100 people) | |
Side effects and what to do | When to contact health care team |
Low neutrophils (white blood cells) in the blood (neutropenia) (May be severe) When neutrophils are low, you are at risk of getting an infection more easily. Ask your health care team for the Neutropenia (Low white blood cell count) pamphlet for more information. What to look for?
You have a fever if your temperature taken in your mouth (oral temperature) is:
What to do? If your health care team has told you that you have low neutrophils:
If you have a fever: If you have a fever, try to contact your health care team. If you are unable to talk to the team for advice, you must get emergency medical help right away.
|
If you have a fever, try to contact your health care team. If you are unable to talk to the team for advice, you MUST get emergency medical help right away. |
Low platelets in the blood (May be severe) When platelets are low, you are at risk for bleeding and bruising. Ask your health care team for the Low Platelet Count pamphlet for more information. What to look for?
What to do? If your health care team has told you that you have low platelets:
If you have signs of bleeding:
If you have bleeding that does not stop or is severe (very heavy), you must get emergency medical help right away.
|
Talk to your health care team if you have any signs of bleeding. If you have bleeding that doesn’t stop or is severe (very heavy), you MUST get emergency medical help right away. |
Anemia (low red blood cells) (May be severe) What to look for?
What to do? If your health care team has told you that you have anemia (low red blood cells):
|
Talk to your health care team if it does not improve or if it is severe |
Nausea and vomiting (Generally mild) What to look for?
What to do? To help prevent nausea:
|
Talk to your health care team if nausea lasts more than 48 hours or vomiting lasts more than 24 hours or if it is severe |
Fatigue What to look for?
What to do?
Ask your health care team for the Fatigue pamphlet for more information. |
Talk to your health care team if it does not improve or if it is severe |
Hair thinning or loss What to look for?
What to do?
|
Talk to your health care team if this bothers you |
Low appetite, weight loss What to look for?
What to do?
Ask your health care team for the Loss of Appetite pamphlet for more information. |
Talk to your health care team if it does not improve or if it is severe |
Diarrhea and other early side effects of irinotecan that start during treatment or within 24 hours What to look for?
What to do?
|
Tell your health care team right away if you have any of these symptoms |
Diarrhea that starts more than 24 hours after treatment.
What to do? If you have diarrhea:
Ask your health care team for the Diarrhea pamphlet for more information. |
Talk to your health care team if no improvement after 24 hours of taking diarrhea medication or if severe (more than 7 times in one day) |
Common Side Effects (25 to 49 out of 100 people) | |
Side effects and what to do | When to contact health care team |
Liver problems Your health care team may check your liver function with a blood test. Liver changes do not usually cause any symptoms.
If you have any symptoms of liver problems, get emergency medical help right away. |
Get emergency medical help right away |
Constipation What to look for?
What to do? To help prevent constipation:
To help treat constipation:
Ask your health care team for the Constipation Pamphlet for more information.
|
Talk to your health care team if it does not improve or if it is severe |
Mouth sores What to look for?
What to do? To help prevent mouth sores:
If you have mouth sores:
Ask your health care team for the Oral Care (Mouth Care) pamphlet for more information. |
Talk to your health care team as soon as you notice mouth or lip sores or if it hurts to eat, drink or swallow |
Eye problems What to look for?
What to do?
|
Contact your health care team as soon as possible |
Less Common Side Effects (10 to 24 out of 100 people) | |
Side effects and what to do | When to contact health care team |
Cough and feeling short of breath (May be severe) What to look for?
What to do?
|
Talk to your health care team. If you are not able to talk to your health care team for advice, and you have a fever or severe symptoms, you MUST get emergency medical help right away |
Rash; dry, itchy skin What to look for?
What to do? To prevent and treat dry skin:
Rash may be severe in some rare cases and cause your skin to blister or peel. If this happens, get emergency medical help right away. |
Talk to your health care team if it does not improve or if it is severe |
Trouble Sleeping Your medications may cause trouble sleeping. It may get better once your body gets used to the medication or when your treatment ends. What to look for?
What to do? Talk to your health care team if it does not improve or if it is severe. |
Talk to your health care team if it does not improve or if it is severe |
Headache; Mild joint, muscle pain or cramps What to look for?
What to do?
Ask your health care team for the Pain pamphlet for more information.
|
Talk to your health care team if it does not improve or if it is severe |
Swelling inside your nose
What to do?
|
Talk to your healthcare team if it does not improve or if it is severe |
Dizziness What to look for?
|
Talk to your health care team if it does not improve or if it is severe |
Rash on your hands and feet (hand-foot syndrome) What to look for?
What to do? To help prevent Hand-foot syndrome:
Ask your health care team for the Hand-foot syndrome pamphlet for more information.
|
Talk to your health care team if it does not improve or if it is severe |
Flushing What to look for?
What to do? Talk to your health care team if no improvement or if severe. |
Talk to your health care team if it does not improve or if it is severe |
Heartburn; upset stomach; bloating What to look for?
What to do?
|
Talk to your health care team if it does not improve or if it is severe |
Mild swelling What to look for?
What to do? To help prevent swelling:
If you have swelling: |
Talk to your health care team if it does not improve or if it is severe |
Other rare, but serious side effects are possible with this treatment.
If you have any of the following, talk to your cancer health care team or get emergency medical help right away:
-
Severe belly pain
-
Severe headache, passing out (fainting)
-
Confusion, seizures
-
Any changes in your vision (eye sight)
-
Coughing up blood or trouble breathing
-
Pain and swelling of a vein in your arm or leg
-
Severe weakness, problems with your balance, or have falls
-
Unusual muscle spasms, tremors, irregular or jerky movements
-
Signs of allergic reaction: flushing, itchiness, rash, swollen lips, face or tongue, wheezing, chest and throat tightness
-
Unusual weight gain
-
Passing very little or no pee
-
Red-brown coloured pee
For more information on how to manage your symptoms ask your health care provider, or visit: https://www.cancercareontario.ca/symptoms.
December 2023 Updated "How will this treatment affect sex, pregnancy and breast feeding?" section
For more links on how to manage your symptoms go to www.cancercareontario.ca/symptoms.
The information set out in the medication information sheets, regimen information sheets, and symptom management information(for patients) contained in the Drug Formulary (the "Formulary") is intended to be used by health professionals and patients for informational purposes only. The information is not intended to cover all possible uses, directions, precautions, drug interactions or side effects of a certain drug, nor should it be used to indicate that use of a particular drug is safe, appropriate or effective for a given condition.
A patient should always consult a healthcare provider if he/she has any questions regarding the information set out in the Formulary. The information in the Formulary is not intended to act as or replace medical advice and should not be relied upon in any such regard. All uses of the Formulary are subject to clinical judgment and actual prescribing patterns may not follow the information provided in the Formulary.
FOLFIRI+BEVA Treatment
This handout gives general information about this cancer treatment.
You will learn:
-
who to contact for help
-
what the treatment is
-
how it is given
-
what to expect while on treatment
This handout was created by Ontario Health (Cancer Care Ontario) together with patients and their caregivers who have also gone through cancer treatment. It is meant to help support you through your cancer treatment and answer some of your questions.
This information does not replace the advice of your health care team. Always talk to your health care team about your treatment.
My cancer health care provider is: _____________________________________________
During the day I should contact: _______________________________________________
Evenings, weekends and holidays: _____________________________________________
This page gives general information about this cancer treatment.
You will learn:
-
who to contact for help
-
what the treatment is
-
how it is given
-
what to expect while on treatment
This information was created by Ontario Health (Cancer Care Ontario) together with patients and their caregivers who have also gone through cancer treatment. It is meant to help support you through your cancer treatment and answer some of your questions.
This information does not replace the advice of your health care team. Always talk to your health care team about your treatment.
FOLFIRI+BEVA is the code name of your colorectal cancer treatment regimen.
A regimen is a combination of medications to treat cancer.
This regimen name is made up of 1 or more letters from the names of the 4 medications in your treatment.
Here are the name(s) of the medication(s) in this regimen:
FOL = FOLinic acid (also called leucovorin)
F = Fluorouracil (also called 5-FU)
IRI = IRInotecan
+
BEVA = BEVAcizumab
Treatment is divided into cycles. Each cycle is 2 weeks long. Your health care team will tell you how many cycles you need.
Here is a picture of the schedule for FOLFIRI+BEVA treatment:
Cycle 1 FOLFIRI+BEVA (2 weeks)
Repeat FOLFIRI+BEVA (2 weeks)
Your health care team will tell you how many cycles you will have.
During each 2-week cycle, you will have FOLFIRI+BEVA treatment on day 1 at the hospital. Your nurse will also start an IV of fluorouracil that will continue at home for a total of 46 hours. See below for more information.
Each cycle looks like this:
Day 1
Treatment Day:
Go to the hospital for FOLFIRI+
BEVA treatment. Fluorouracil infusion will continue for 46 hours.
2
Fluorouracil
infusion
continues
at home.
3
Fluorouracil infusion continues at home. A nurse will disconnect it.
4
No
FOLFIRI+
BEVA
Treatment
5
6
7
8
9
10
11
12
13
14
Remember To:
-
Tell your health care team about all of the other medications you are taking.
-
Keep taking other medications that have been prescribed for you, unless you have been told not to by your health care team.
Your health care team may ask you to have a blood test to check for DPD deficiency before starting treatment.
- DPD deficiency is when you have low or no activity of an enzyme called DPD (dihydropyrimidine dehydrogenase). A deficiency can cause you to have severe side effects from fluorouracil.
- See the Testing for people taking capecitabine or 5-fluorouracil (5-FU) pamphlet for more information.
You will have a blood test to check for hepatitis B before starting treatment. See the Hepatitis B and Cancer Medications pamphlet for more information.
The medications in your treatment are given through an IV (injected into a vein) at the hospital on day 1 of your treatment. You will also be given a device to take home that will continue to give you fluorouracil at home. The device looks like a bottle. It slowly gives you fluorouracil over 46 hours.
Your health care team may suggest that you get a PICC line or a Port-a-Cath.
-
These are special IV’s used to give medicines and fluids into larger veins.
-
A PICC or Port-a-Cath can be safer for some medications that can cause reactions
when given through an IV in your hand. -
If you have a PICC or Port-a-Cath you do not need an IV (needle) put into your arm
every time you come for treatment.
- Talk to your healthcare team about the benefits and risks of a PICC or a Port-a-Cath to see if one of these options is right for you.
You will have a blood test before each treatment cycle to make sure it is safe for you to get treatment.
To Prevent Nausea and Vomiting
You will be given medications to help prevent nausea (feeling like throwing up) and vomiting (throwing up) before they start.
- These are called anti-nausea medications and include medications such as ondansetron (Zofran®), granisetron (Kytril®), dexamethasone or others.
To Treat Diarrhea
The Irinotecan in your treatment regimen can cause diarrhea. Diarrhea is when you have loose bowel movements (watery poo) or you need to go poo (have bowel movements) more often than usual. Diarrhea may start a few days after your treatment.
You will be given a medication called loperamide (Imodium®) to help treat your diarrhea. Take this medication only if you need it.
Keep your loperamide with you all the time. When diarrhea starts, take the loperamide right away
If you start to have diarrhea
- Take 2 tablets (4mg) of loperamide right away.
- Take 1 tablet (2mg) every 2 hours after that.
- During the night you may take 2 tablets (4mg) every 4 hours.
- Keep taking loperamide until you have no diarrhea for 12 hours.
-
DO tell your health care team about any other medical conditions that you have such as heart, liver, lung or kidney problems, diabetes or any allergies.
-
DO check with your health care team before getting any vaccinations, surgery, dental work or other medical procedures.
-
DO protect your skin from the sun. Wear a long sleeved shirt, long pants and a hat. Apply sunscreen with UVA and UVB protection and an SPF of at least 30. Your skin may be more sensitive to the sun and you could develop a bad sunburn or rash more easily.
-
DO talk to your health care team about your risk of heart problems with this treatment.
-
DO consider asking someone to drive you to and from the hospital on your treatment days. You may feel drowsy or dizzy after your treatment.
-
DO NOT take any other medications, such as vitamins, over-the-counter (non-prescription) drugs, or natural health products, without checking with your health care team.
-
DO NOT start any complementary or alternative therapies, such as acupuncture or homeopathic medications, without checking with your health care team.
-
DO NOT eat or drink grapefruit, starfruit, Seville oranges or their juices (or products that contain these) while on this treatment. They may increase side effects.
-
DO NOT smoke or drink alcohol while on treatment without talking to your health care team first. Smoking and drinking can make side effects worse and make your treatment not work as well.
-
DO tell your health care team about any other medical conditions that you have such as heart, liver, lung or kidney problems, diabetes or any allergies.
-
DO check with your health care team before getting any vaccinations, surgery, dental work or other medical procedures.
-
DO protect your skin from the sun. Wear a long sleeved shirt, long pants and a hat. Apply sunscreen with UVA and UVB protection and an SPF of at least 30. Your skin may be more sensitive to the sun and you could develop a bad sunburn or rash more easily.
-
DO talk to your health care team about your risk of heart problems with this treatment.
-
DO consider asking someone to drive you to and from the hospital on your treatment days. You may feel drowsy or dizzy after your treatment.
-
DO NOT take any other medications, such as vitamins, over-the-counter (non-prescription) drugs, or natural health products, without checking with your health care team.
-
DO NOT start any complementary or alternative therapies, such as acupuncture or homeopathic medications, without checking with your health care team.
-
DO NOT eat or drink grapefruit, starfruit, Seville oranges or their juices (or products that contain these) while on this treatment. They may increase side effects.
-
DO NOT smoke or drink alcohol while on treatment without talking to your health care team first. Smoking and drinking can make side effects worse and make your treatment not work as well.
Yes, the medications in this regimen can interact with other medications, vitamins, foods and natural health products. Interactions can make the treatment not work as well or cause severe side effects.
Tell your health care team about all of your:
- prescription and over-the-counter (non-prescription) medications
- natural health products such as vitamins, herbal teas, homeopathic medicines and other supplements
Check with your health care team before starting or stopping any of them.
If you are taking seizure medications (such as phenytoin), your health care team will monitor your blood levels closely and may change your dose.
- Anti-inflammatory medications such as ibuprofen (Advil® or Motrin®), naproxen (Aleve®) or Aspirin®.
- Over-the-counter products such as dimenhydrinate (Gravol®)
- Natural health products such as St. John’s Wort
- Supplements such as vitamin C
- Alcoholic drinks
- Tobacco
- All other drugs, such as marijuana (medical or recreational)
-
Always check your temperature to see if you have a fever before taking any medications for fever or pain (such as acetaminophen (Tylenol®) or ibuprofen (Advil®)).
-
Fever can be a sign of infection that may need treatment right away.
-
If you take these medications before you check for fever, they may lower your temperature and you may not know you have an infection.
-
How to check for fever:
Keep a digital (electronic) thermometer at home and take your temperature if you feel hot or unwell (for example, chills, headache, mild pain).
-
You have a fever if your temperature taken in your mouth (oral temperature) is:
-
38.3°C (100.9°F) or higher at any time
-
-
OR
-
38.0°C (100.4°F) or higher for at least one hour.
-
If you do have a fever:
-
Try to contact your health care team. If you are not able to talk to them for advice, you MUST get emergency medical help right away.
-
Ask your health care team for the Fever pamphlet for more information.
If you do not have a fever but have mild symptoms such as headache or mild pain:
- Ask your health care team about the right medication for you. Acetaminophen (Tylenol®) is a safe choice for most people.
Talk to your health care team before you start taking ibuprofen (Advil®, Motrin®), naproxen (Aleve®) or ASA (Aspirin®), as they may increase your chance of bleeding or interact with your cancer treatment.
Talk to your health care team if you already take low dose aspirin for a medical condition (such as a heart problem). It may still be safe to take.
Talk to your health care team about:
-
How this treatment may affect your sexual health.
-
How this treatment may affect your ability to have a baby, if this applies to you.
This treatment may harm an unborn baby. Tell your health care team if you or your partner are pregnant, become pregnant during treatment, or are breastfeeding.
- If there is any chance of pregnancy happening, you and your partner together must use 2 effective forms of birth control at the same time while you are on treatment. Talk to your health care team about which birth control options are best for you, and how long you should use them after your last treatment dose.
- Do not breastfeed while on this treatment. Talk to your health care team about how long to wait before you start breastfeeding after your last treatment dose, if this applies to you.
The following table lists side effects that you may have when getting FOLFIRI+BEVA treatment. The table is set up to list the most common side effects first and the least common last. It is unlikely that you will have all of the side effects listed and you may have some that are not listed.
Read over the side effect table so that you know what to look for and when to get help. Keep this information during your treatment, so that you can refer to it if you need to.
It is common for people who are treated with FOLFIRI+BEVA to have mild side effects only.
Very Common Side Effects (50 or more out of 100 people) | |
Side effects and what to do | When to contact health care team |
Low neutrophils (white blood cells) in the blood (neutropenia)(May be severe) When neutrophils are low, you are at risk of getting an infection more easily. Ask your health care team for the Neutropenia (Low white blood cell count) pamphlet for more information. What to look for:
You have a fever if your temperature taken in your mouth (oral temperature) is:
OR
What to do:If your health care team has told you that you have low neutrophils:
If you have a fever: If you have a fever, try to contact your health care team. If you are unable to talk to the team for advice, you must get emergency medical help right away.
|
If you have a fever, try to contact your health care team. If you are unable to talk to the team for advice, you MUST get emergency medical help right away. |
Low platelets in the blood(May be severe) When your platelets are low you are at risk for bleeding and bruising. Ask your health care team for the Low Platelet Count pamphlet for more information. What to look for:
What to do:If your health care team has told you that you have low platelets:
|
Talk to your health care team if you have any signs of bleeding. If you have bleeding that doesn’t stop or is severe (very heavy), you MUST get emergency medical help right away. |
Anemia (low red blood cells)(May be severe) What to look for:
|
Talk to your health care team if it does not improve or if it is severe |
Nausea and vomiting(Generally mild) What to look for:
|
Talk to your health care team if nausea lasts more than 48 hours or vomiting lasts more than 24 hours or if it is severe |
FatigueWhat to look for:
What to do:
Ask your health care team for the Fatigue pamphlet for more information.
|
Talk to your health care team if it does not improve or if it is severe |
Hair thinning or loss(Generally mild) What to look for:
|
Talk to your health care team if this bothers you |
Low Appetite, weight lossWhat to look for:
What to do:
See our Loss of Appetite pamphlet for more information. |
Talk to your health care team if it does not improve or if it is severe |
Diarrhea and other early side effects of irinotecan that start during treatment or within 24 hours What to look for:
|
Tell your health care team right away if you have any of these symptoms |
Diarrhea that starts more than 24 hours after treatment.
What to look for:If you have diarrhea:
Ask your health care team for the Diarrhea pamphlet for more information. |
Talk to your health care team if no improvement after 24 hours of taking diarrhea medication or if severe (more than 7 times in 1 day) |
Common Side Effects (25 to 49 out of 100 people) | |
Side effects and what to do | When to contact health care team |
High blood pressureWhat to look for:
What to do:
If you have a severe headache get emergency help right away as it may be a sign your blood pressure is too high. |
Talk to your health care team if it does not improve or if it is severe |
Proteins in Urine (pee)Your health care team may do urine tests to check for proteins in your pee.
|
Talk to your health care team if it does not improve or if it is severe |
Headache, mild joint, muscle pain or crampsWhat to look for:New pain in your muscles or joints, muscle cramps, or feeling achy.
|
Talk to your health care team if it does not improve or if it is severe |
Liver problemsYour health care team may check your liver function with a blood test. Liver changes do not usually cause any symptoms.
|
Get emergency medical help right away |
ConstipationWhat to look for:
|
Talk to your health care team if it does not improve or if it is severe |
Mouth soresWhat to look for:
|
Talk to your health care team as soon as you notice mouth or lip sores, or if it hurts to eat, drink or swallow |
Eye problemsWhat to look for:
|
Talk to your health care team as soon as possible |
Less Common Side Effects (10 to 24 out of 100 people) | |
Side effects and what to do | When to contact health care team |
Rash; dry, itchy skinWhat to look for:
|
Talk to your health care team if it does not improve or if it is severe |
Trouble SleepingYour medications may cause trouble sleeping. It may get better once your body gets used to the medication or when your treatment ends. What to look for:
What to do:Talk to your health care team if it does not improve or if it is severe. |
Talk to your health care team if it does not improve or if it is severe |
Blood clotsWhat to look for:
A blood clot in your lungs can cause: coughing, problems breathing, pain in your chest or coughing up blood A blood clot in your brain (stroke) can cause: trouble seeing, speaking, or using your arms and legs A blood clot in your heart (heart attack) can cause: chest pain, shortness of breath and pain in your belly or arms
|
Get emergency medical help right away |
Swelling inside your noseWhat to look for:
What to do:Talk to your health care team if it does not improve or if it is severe. |
Talk to your health care team if it does not improve or if it is severe |
DizzinessWhat to look for:
What to do:
|
Talk to your health care team if it does not improve or if it is severe |
Cough and feeling short of breathWhat to look for:
|
Talk to your health care team. If you are not able to talk to your health care team for advice, and you have a fever or severe symptoms, you MUST get emergency medical help right away. |
Heart problemsWhat to look for:
What to do:Get emergency medical help right away. |
Get emergency medical help right away |
Rash on your hands and feet (hand-foot syndrome)What to look for:
|
Talk to your health care team if it does not improve or if it is severe |
Heartburn, upset stomach and bloatingWhat to look for:
|
Talk to your health care team if it does not improve or if it is severe |
FlushingWhat to look for:
What to do:Talk to your health care team if no improvement or if severe. |
Talk to your health care team if it does not improve or if it is severe |
Speech problemsWhat to look for:
What to do:Talk to your health care team if no improvement or if severe. |
Talk to your health care team if it does not improve or if it is severe |
Mild swelling What to look for:
What to do:To help prevent swelling:
If you have swelling:
|
Talk to your health care team if it does not improve or if it is severe |
Other rare, but serious side effects are possible with this treatment.
If you have any of the following, talk to your cancer health care team or get emergency medical help right away:
- Signs of allergic reaction: flushing, itchiness, rash, swollen lips, face or tongue, wheezing, chest and throat tightness
- Severe belly pain
- Any new teeth or mouth pain and swelling, mouth sores that do not heal, unusual discharge from gums, loosening of teeth and the feeling of numbness or heaviness in the jaw
- Severe headache, passing out (fainting)
- Confusion, seizures
- Any changes to your vision
- Severe weakness, problems with your balance or have falls
- Unusual muscle spasms, tremors, irregular or jerky movements
- Redness or rash in areas where you had radiation before
- Red-brown coloured pee
- Wounds that take longer than normal to heal or don’t fully heal
For more information on how to manage your symptoms ask your health care provider, or visit: https://www.cancercareontario.ca/symptoms.
December 2023 Updated "How will this treatment affect sex, pregnancy and breast feeding?" section
For more links on how to manage your symptoms go to www.cancercareontario.ca/symptoms.
The information set out in the medication information sheets, regimen information sheets, and symptom management information(for patients) contained in the Drug Formulary (the "Formulary") is intended to be used by health professionals and patients for informational purposes only. The information is not intended to cover all possible uses, directions, precautions, drug interactions or side effects of a certain drug, nor should it be used to indicate that use of a particular drug is safe, appropriate or effective for a given condition.
A patient should always consult a healthcare provider if he/she has any questions regarding the information set out in the Formulary. The information in the Formulary is not intended to act as or replace medical advice and should not be relied upon in any such regard. All uses of the Formulary are subject to clinical judgment and actual prescribing patterns may not follow the information provided in the Formulary.




